ThéCell is a non-profit provincial network supported by the Fonds de recherche du Québec – Santé (FRQS). Its mission is dedicated to further Cell, Gene and Tissue therapies. ThéCell mobilizes researchers and resources for the development of new therapeutic approaches in regenerative medicine. It aims to accelerate the translation of discoveries stemming from Quebec laboratories toward clinical applications and treatments. The network acts as a catalyst to promote the collaboration between more than 135 researchers, clinicians and their teams (over 360 students and post-docs and 170 associate members) involved in key health research areas of cell, tissue and gene therapy, namely: 1) musculoskeletal and nervous systems; 2) cardiovascular, pulmonary, renal and digestive systems; 3) skin and cornea systems; and 4) hematology, oncology and immunology. Seven infrastructures support the activities of the network including: preclinical, ethical, social and legal guidance, economic evaluation as well as GMP production facilities for cells, genes and tissues used in clinical trials. ThéCell plays a central role in Quebec’s regenerative medicine landscape by strengthening scientific exchanges and promoting the emergence of new partnerships within Canada and internationally.